Loading…

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16

HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer Department of Pathology, Free University Hospital, Amsterdam, The Netherlands. To investigate whether there is an association between local or systemic IgG and IgA responses agains...

Full description

Saved in:
Bibliographic Details
Published in:Journal of general virology 1999-02, Vol.80 (2), p.409-417
Main Authors: Bontkes, HJ, de Gruijl, TD, Walboomers, JM, Schiller, JT, Dillner, J, Helmerhorst, TJ, Verheijen, RH, Scheper, RJ, Meijer, CJ
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3
cites
container_end_page 417
container_issue 2
container_start_page 409
container_title Journal of general virology
container_volume 80
creator Bontkes, HJ
de Gruijl, TD
Walboomers, JM
Schiller, JT
Dillner, J
Helmerhorst, TJ
Verheijen, RH
Scheper, RJ
Meijer, CJ
description HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer Department of Pathology, Free University Hospital, Amsterdam, The Netherlands. To investigate whether there is an association between local or systemic IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like particles (VLP) containing L1 and L2 and the possible influence of these responses on clearance of HPV-16 and its associated lesions, cervical mucus samples from 125 patients and plasma samples from 100 patients, all participating in a non-intervention cohort study of women with abnormal cytology, were analysed. The results show that local IgG and IgA HPV-16 VLP-specific antibodies do not correlate with virus clearance. However, systemic IgG responses were more frequently detected in patients with a persistent infection (11/24) compared with patients with cleared HPV-16 infections (3/28, P = 0.006). Furthermore, the ultimate development of high-grade lesions was associated with systemic VLP-specific IgG reactivity (P = 0.026). By contrast, systemic IgA responses were correlated with virus clearance (7/28 clearance compared with 1/24 persistence patients, P = 0.06). This correlation was statistically significant when only those clearance patients who tested HPV-16 DNA-positive at more than one visit were included in the analysis (5/11 compared with 1/24, P = 0.007). As these systemic IgA responses were not accompanied by local IgA responses, the systemic IgA responses in HPV-16 clearance patients are suggested to be a by-product of a successful cellular immune response induced at the local lymph nodes, mediated by cytokines.
doi_str_mv 10.1099/0022-1317-80-2-409
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_606253</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17295165</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3</originalsourceid><addsrcrecordid>eNqFksuOFCEUhitG44yjL-DCsPKyoIWiistyMlGnk0k08bIlFHW6G4cqSqCm02_ro0jbbTsb4wo4fP_PyeGvqueULChR6i0hdY0powJLgmvcEPWgOqcNb3Fdrh9W5yfgrHqS0ndCaNO04nF1RgkRTBB6Xv1cDsM8AoqQpjAmSMisjRtTRpt5MCOazOS8D4O5c3FO6PX1p29vUN5NgChHv2vYu1soXMzO-qJ3IzLIhk2IGaU89zsUVmgbBhjR1uUNshDvnDW-gDkamEoNvCvnEcLkTXJmgZbLBfq8SxkGZ1E3ZzSGjHzYq5bry3vN2hAjeJPh6O3BRDNa2L9ZWsWUP60erYxP8Oy4XlRf37_7cnWNbz5-WF5d3mDbqDpjbgVAb5ngQoBUjBjGJbGkX3VMKiIttWV2qu6osFQSKlQjWGNkJ01vOQN2UeGDb9rCNHd6im4wcaeDcfpYui070JzwumWFF__kpxj6v6I_QqpaJhtZlC8PyoL9mCFlPbhkwXtTJjgnzRWnpTfyX5CKWrWUtwWsD6CNIaUIq1M3lOh91PQ-SXqfJC2JrnWJWhG9OLrP3QD9PckhWwV4dQA2br3Zugh6DWP50Bg6F3TJzsnqFxlu4ZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17295165</pqid></control><display><type>article</type><title>Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16</title><source>Freely Accessible Science Journals - check A-Z of ejournals</source><creator>Bontkes, HJ ; de Gruijl, TD ; Walboomers, JM ; Schiller, JT ; Dillner, J ; Helmerhorst, TJ ; Verheijen, RH ; Scheper, RJ ; Meijer, CJ</creator><creatorcontrib>Bontkes, HJ ; de Gruijl, TD ; Walboomers, JM ; Schiller, JT ; Dillner, J ; Helmerhorst, TJ ; Verheijen, RH ; Scheper, RJ ; Meijer, CJ</creatorcontrib><description>HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer Department of Pathology, Free University Hospital, Amsterdam, The Netherlands. To investigate whether there is an association between local or systemic IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like particles (VLP) containing L1 and L2 and the possible influence of these responses on clearance of HPV-16 and its associated lesions, cervical mucus samples from 125 patients and plasma samples from 100 patients, all participating in a non-intervention cohort study of women with abnormal cytology, were analysed. The results show that local IgG and IgA HPV-16 VLP-specific antibodies do not correlate with virus clearance. However, systemic IgG responses were more frequently detected in patients with a persistent infection (11/24) compared with patients with cleared HPV-16 infections (3/28, P = 0.006). Furthermore, the ultimate development of high-grade lesions was associated with systemic VLP-specific IgG reactivity (P = 0.026). By contrast, systemic IgA responses were correlated with virus clearance (7/28 clearance compared with 1/24 persistence patients, P = 0.06). This correlation was statistically significant when only those clearance patients who tested HPV-16 DNA-positive at more than one visit were included in the analysis (5/11 compared with 1/24, P = 0.007). As these systemic IgA responses were not accompanied by local IgA responses, the systemic IgA responses in HPV-16 clearance patients are suggested to be a by-product of a successful cellular immune response induced at the local lymph nodes, mediated by cytokines.</description><identifier>ISSN: 0022-1317</identifier><identifier>EISSN: 1465-2099</identifier><identifier>DOI: 10.1099/0022-1317-80-2-409</identifier><identifier>PMID: 10073701</identifier><language>eng</language><publisher>England: Soc General Microbiol</publisher><subject>Adolescent ; Adult ; Antibodies, Viral - biosynthesis ; Capsid - immunology ; Capsid Proteins ; Cervical Intraepithelial Neoplasia - complications ; Cervical Intraepithelial Neoplasia - immunology ; Cervical Intraepithelial Neoplasia - virology ; Cohort Studies ; DNA, Viral - isolation &amp; purification ; Female ; Follow-Up Studies ; Human papillomavirus 16 ; Humans ; Immunity, Cellular ; Immunoglobulin A - biosynthesis ; Immunoglobulin G - biosynthesis ; Medicin och hälsovetenskap ; Middle Aged ; Oncogene Proteins, Viral - immunology ; Papillomaviridae - classification ; Papillomaviridae - immunology ; Papillomaviridae - pathogenicity ; Papillomavirus Infections - complications ; Papillomavirus Infections - immunology ; Tumor Virus Infections - complications ; Tumor Virus Infections - immunology ; Uterine Cervical Neoplasms - complications ; Uterine Cervical Neoplasms - immunology ; Uterine Cervical Neoplasms - virology</subject><ispartof>Journal of general virology, 1999-02, Vol.80 (2), p.409-417</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10073701$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1953848$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Bontkes, HJ</creatorcontrib><creatorcontrib>de Gruijl, TD</creatorcontrib><creatorcontrib>Walboomers, JM</creatorcontrib><creatorcontrib>Schiller, JT</creatorcontrib><creatorcontrib>Dillner, J</creatorcontrib><creatorcontrib>Helmerhorst, TJ</creatorcontrib><creatorcontrib>Verheijen, RH</creatorcontrib><creatorcontrib>Scheper, RJ</creatorcontrib><creatorcontrib>Meijer, CJ</creatorcontrib><title>Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16</title><title>Journal of general virology</title><addtitle>J Gen Virol</addtitle><description>HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer Department of Pathology, Free University Hospital, Amsterdam, The Netherlands. To investigate whether there is an association between local or systemic IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like particles (VLP) containing L1 and L2 and the possible influence of these responses on clearance of HPV-16 and its associated lesions, cervical mucus samples from 125 patients and plasma samples from 100 patients, all participating in a non-intervention cohort study of women with abnormal cytology, were analysed. The results show that local IgG and IgA HPV-16 VLP-specific antibodies do not correlate with virus clearance. However, systemic IgG responses were more frequently detected in patients with a persistent infection (11/24) compared with patients with cleared HPV-16 infections (3/28, P = 0.006). Furthermore, the ultimate development of high-grade lesions was associated with systemic VLP-specific IgG reactivity (P = 0.026). By contrast, systemic IgA responses were correlated with virus clearance (7/28 clearance compared with 1/24 persistence patients, P = 0.06). This correlation was statistically significant when only those clearance patients who tested HPV-16 DNA-positive at more than one visit were included in the analysis (5/11 compared with 1/24, P = 0.007). As these systemic IgA responses were not accompanied by local IgA responses, the systemic IgA responses in HPV-16 clearance patients are suggested to be a by-product of a successful cellular immune response induced at the local lymph nodes, mediated by cytokines.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antibodies, Viral - biosynthesis</subject><subject>Capsid - immunology</subject><subject>Capsid Proteins</subject><subject>Cervical Intraepithelial Neoplasia - complications</subject><subject>Cervical Intraepithelial Neoplasia - immunology</subject><subject>Cervical Intraepithelial Neoplasia - virology</subject><subject>Cohort Studies</subject><subject>DNA, Viral - isolation &amp; purification</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Human papillomavirus 16</subject><subject>Humans</subject><subject>Immunity, Cellular</subject><subject>Immunoglobulin A - biosynthesis</subject><subject>Immunoglobulin G - biosynthesis</subject><subject>Medicin och hälsovetenskap</subject><subject>Middle Aged</subject><subject>Oncogene Proteins, Viral - immunology</subject><subject>Papillomaviridae - classification</subject><subject>Papillomaviridae - immunology</subject><subject>Papillomaviridae - pathogenicity</subject><subject>Papillomavirus Infections - complications</subject><subject>Papillomavirus Infections - immunology</subject><subject>Tumor Virus Infections - complications</subject><subject>Tumor Virus Infections - immunology</subject><subject>Uterine Cervical Neoplasms - complications</subject><subject>Uterine Cervical Neoplasms - immunology</subject><subject>Uterine Cervical Neoplasms - virology</subject><issn>0022-1317</issn><issn>1465-2099</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFksuOFCEUhitG44yjL-DCsPKyoIWiistyMlGnk0k08bIlFHW6G4cqSqCm02_ro0jbbTsb4wo4fP_PyeGvqueULChR6i0hdY0powJLgmvcEPWgOqcNb3Fdrh9W5yfgrHqS0ndCaNO04nF1RgkRTBB6Xv1cDsM8AoqQpjAmSMisjRtTRpt5MCOazOS8D4O5c3FO6PX1p29vUN5NgChHv2vYu1soXMzO-qJ3IzLIhk2IGaU89zsUVmgbBhjR1uUNshDvnDW-gDkamEoNvCvnEcLkTXJmgZbLBfq8SxkGZ1E3ZzSGjHzYq5bry3vN2hAjeJPh6O3BRDNa2L9ZWsWUP60erYxP8Oy4XlRf37_7cnWNbz5-WF5d3mDbqDpjbgVAb5ngQoBUjBjGJbGkX3VMKiIttWV2qu6osFQSKlQjWGNkJ01vOQN2UeGDb9rCNHd6im4wcaeDcfpYui070JzwumWFF__kpxj6v6I_QqpaJhtZlC8PyoL9mCFlPbhkwXtTJjgnzRWnpTfyX5CKWrWUtwWsD6CNIaUIq1M3lOh91PQ-SXqfJC2JrnWJWhG9OLrP3QD9PckhWwV4dQA2br3Zugh6DWP50Bg6F3TJzsnqFxlu4ZA</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>Bontkes, HJ</creator><creator>de Gruijl, TD</creator><creator>Walboomers, JM</creator><creator>Schiller, JT</creator><creator>Dillner, J</creator><creator>Helmerhorst, TJ</creator><creator>Verheijen, RH</creator><creator>Scheper, RJ</creator><creator>Meijer, CJ</creator><general>Soc General Microbiol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>19990201</creationdate><title>Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16</title><author>Bontkes, HJ ; de Gruijl, TD ; Walboomers, JM ; Schiller, JT ; Dillner, J ; Helmerhorst, TJ ; Verheijen, RH ; Scheper, RJ ; Meijer, CJ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antibodies, Viral - biosynthesis</topic><topic>Capsid - immunology</topic><topic>Capsid Proteins</topic><topic>Cervical Intraepithelial Neoplasia - complications</topic><topic>Cervical Intraepithelial Neoplasia - immunology</topic><topic>Cervical Intraepithelial Neoplasia - virology</topic><topic>Cohort Studies</topic><topic>DNA, Viral - isolation &amp; purification</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Human papillomavirus 16</topic><topic>Humans</topic><topic>Immunity, Cellular</topic><topic>Immunoglobulin A - biosynthesis</topic><topic>Immunoglobulin G - biosynthesis</topic><topic>Medicin och hälsovetenskap</topic><topic>Middle Aged</topic><topic>Oncogene Proteins, Viral - immunology</topic><topic>Papillomaviridae - classification</topic><topic>Papillomaviridae - immunology</topic><topic>Papillomaviridae - pathogenicity</topic><topic>Papillomavirus Infections - complications</topic><topic>Papillomavirus Infections - immunology</topic><topic>Tumor Virus Infections - complications</topic><topic>Tumor Virus Infections - immunology</topic><topic>Uterine Cervical Neoplasms - complications</topic><topic>Uterine Cervical Neoplasms - immunology</topic><topic>Uterine Cervical Neoplasms - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bontkes, HJ</creatorcontrib><creatorcontrib>de Gruijl, TD</creatorcontrib><creatorcontrib>Walboomers, JM</creatorcontrib><creatorcontrib>Schiller, JT</creatorcontrib><creatorcontrib>Dillner, J</creatorcontrib><creatorcontrib>Helmerhorst, TJ</creatorcontrib><creatorcontrib>Verheijen, RH</creatorcontrib><creatorcontrib>Scheper, RJ</creatorcontrib><creatorcontrib>Meijer, CJ</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Journal of general virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bontkes, HJ</au><au>de Gruijl, TD</au><au>Walboomers, JM</au><au>Schiller, JT</au><au>Dillner, J</au><au>Helmerhorst, TJ</au><au>Verheijen, RH</au><au>Scheper, RJ</au><au>Meijer, CJ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16</atitle><jtitle>Journal of general virology</jtitle><addtitle>J Gen Virol</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>80</volume><issue>2</issue><spage>409</spage><epage>417</epage><pages>409-417</pages><issn>0022-1317</issn><eissn>1465-2099</eissn><abstract>HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer Department of Pathology, Free University Hospital, Amsterdam, The Netherlands. To investigate whether there is an association between local or systemic IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like particles (VLP) containing L1 and L2 and the possible influence of these responses on clearance of HPV-16 and its associated lesions, cervical mucus samples from 125 patients and plasma samples from 100 patients, all participating in a non-intervention cohort study of women with abnormal cytology, were analysed. The results show that local IgG and IgA HPV-16 VLP-specific antibodies do not correlate with virus clearance. However, systemic IgG responses were more frequently detected in patients with a persistent infection (11/24) compared with patients with cleared HPV-16 infections (3/28, P = 0.006). Furthermore, the ultimate development of high-grade lesions was associated with systemic VLP-specific IgG reactivity (P = 0.026). By contrast, systemic IgA responses were correlated with virus clearance (7/28 clearance compared with 1/24 persistence patients, P = 0.06). This correlation was statistically significant when only those clearance patients who tested HPV-16 DNA-positive at more than one visit were included in the analysis (5/11 compared with 1/24, P = 0.007). As these systemic IgA responses were not accompanied by local IgA responses, the systemic IgA responses in HPV-16 clearance patients are suggested to be a by-product of a successful cellular immune response induced at the local lymph nodes, mediated by cytokines.</abstract><cop>England</cop><pub>Soc General Microbiol</pub><pmid>10073701</pmid><doi>10.1099/0022-1317-80-2-409</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1317
ispartof Journal of general virology, 1999-02, Vol.80 (2), p.409-417
issn 0022-1317
1465-2099
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_606253
source Freely Accessible Science Journals - check A-Z of ejournals
subjects Adolescent
Adult
Antibodies, Viral - biosynthesis
Capsid - immunology
Capsid Proteins
Cervical Intraepithelial Neoplasia - complications
Cervical Intraepithelial Neoplasia - immunology
Cervical Intraepithelial Neoplasia - virology
Cohort Studies
DNA, Viral - isolation & purification
Female
Follow-Up Studies
Human papillomavirus 16
Humans
Immunity, Cellular
Immunoglobulin A - biosynthesis
Immunoglobulin G - biosynthesis
Medicin och hälsovetenskap
Middle Aged
Oncogene Proteins, Viral - immunology
Papillomaviridae - classification
Papillomaviridae - immunology
Papillomaviridae - pathogenicity
Papillomavirus Infections - complications
Papillomavirus Infections - immunology
Tumor Virus Infections - complications
Tumor Virus Infections - immunology
Uterine Cervical Neoplasms - complications
Uterine Cervical Neoplasms - immunology
Uterine Cervical Neoplasms - virology
title Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A09%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20responses%20against%20human%20papillomavirus%20(HPV)%20type%2016%20virus-like%20particles%20in%20a%20cohort%20study%20of%20women%20with%20cervical%20intraepithelial%20neoplasia.%20II.%20Systemic%20but%20not%20local%20IgA%20responses%20correlate%20with%20clearance%20of%20HPV-16&rft.jtitle=Journal%20of%20general%20virology&rft.au=Bontkes,%20HJ&rft.date=1999-02-01&rft.volume=80&rft.issue=2&rft.spage=409&rft.epage=417&rft.pages=409-417&rft.issn=0022-1317&rft.eissn=1465-2099&rft_id=info:doi/10.1099/0022-1317-80-2-409&rft_dat=%3Cproquest_swepu%3E17295165%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17295165&rft_id=info:pmid/10073701&rfr_iscdi=true